샘플 요청 목록

 카트 문의
시장보고서
상품코드
1908540

세포치료용 원료 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문별 예측(2026-2033년)

Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report, By Product (Media, Sera, Antibodies, Reagents & Buffers), By End Use (CROs & CMOs, Biopharmaceutical & Pharmaceutical Companies), By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세포치료용 원료 시장 개요

세계의 세포치료용 원료 시장 규모는 2025년에 54억 7,000만 달러로 평가되었고, 2033년에는 218억 8,000만 달러에 달할 것으로 예측되고 있습니다.

2026-2033년에는 CAGR 19.15%를 나타낼 것으로 예상됩니다. 배양 배지나 혈청 등의 세포 배양 제품의 혁신뿐만 아니라 암, 당뇨병, 자가면역 질환 등의 만성 질환의 유병률 증가가 예측 기간 중 시장 성장을 견인할 것으로 전망됩니다.

본 보고서는 2021년부터 2033년까지의 각 부문에서의 수익 성장 예측과 최신 동향 분석을 제공합니다. 그랜드뷰 리서치는 본 보고서에서 제품, 최종 용도 및 지역에 따라 세계의 세포치료용 원료 시장 보고서를 세분화합니다.

자주 묻는 질문

  • 세포치료용 원료 시장의 규모는 어떻게 변할 것으로 예상되나요?
  • 세포치료용 원료 시장의 성장 요인은 무엇인가요?
  • 세포치료용 원료 시장의 주요 제품군은 무엇인가요?
  • 세포치료용 원료 시장의 최종 용도는 어떻게 나뉘나요?
  • 세포치료용 원료 시장의 지역별 점유율은 어떻게 되나요?
  • 세포치료용 원료 시장의 주요 기업은 어디인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수와 동향

  • 시장 동향 전망
    • 상위 시장 전망
    • 관련·부수 시장 전망
  • 시장 역학
  • 산업 분석도구
    • Porter's Five Forces 분석
    • PESTEL 분석

제4장 제품별 비즈니스 분석

  • 세포치료용 원료 시장 : 제품별 변동 분석
  • 세포치료용 원료 시장 규모와 동향 분석(제품별, 2021-2033년)
  • 배지
  • 혈청
  • 세포 배양용 보충제
  • 항체
  • 시약 및 완충액
  • 기타

제5장 최종 용도별 비즈니스 분석

  • 세포치료용 원료 시장 : 최종 용도별 변동 분석
  • 바이오의약품 및 제약 기업
  • CRO 및 CMO
  • 기타

제6장 지역별 비즈니스 분석

  • 세포치료용 원료의 지역별 시장 점유율(2025년 및 2033년)
  • 북미
    • 북미의 세포치료용 원료 시장(2021-2033년)
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 유럽의 세포치료용 원료 시장(2021-2033년)
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 아시아태평양의 세포치료용 원료 시장(2021-2033년)
    • 일본
    • 중국
    • 인도
    • 호주
    • 태국
    • 한국
  • 라틴아메리카
    • 라틴아메리카의 세포치료용 원료 시장(2021-2033년)
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 중동 및 아프리카의 세포치료용 원료 시장(2021-2033년)
    • 남아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제7장 경쟁 구도

  • 기업 분류
  • 전략 매핑
  • 기업 포지션 분석(2025년)
  • 기업 프로파일
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Actylis.
    • ACROBiosystems
    • STEMCELL Technologies
    • Grifols, SA
    • Charles River Laboratories
    • RoosterBio, Inc.
    • PromoCell GmbH
    • Danaher
    • Sartorius Stedim BIoTech
KTH 26.01.23

Cell Therapy Raw Materials Market Summary

The global cell therapy raw materials market size was estimated at USD 5.47 billion in 2025 and is projected to reach USD 21.88 billion by 2033, growing at a CAGR of 19.15% from 2026 to 2033. Innovation in cell culture products, including media and sera, and the increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders are expected to drive the market over the forecast period.

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell therapy raw materials market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Media
  • Sera
  • Cell Culture Supplements
  • Antibodies
  • Reagents & Buffers
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Others
  • Regional Outlook (Revenue, USD Million, 2021- 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising demand for cell therapies
      • 3.2.1.2. Advancements in research and development for cell-based therapies
      • 3.2.1.3. Technological Innovation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with the production and procurement of raw materials
      • 3.2.2.2. Stringent regulations associated with cell therapies
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Cell Therapy Raw Materials Market: Product Movement Analysis
  • 4.3. Cell Therapy Raw Materials Market Size & Trend Analysis, By Product, 2021 to 2033 (USD Million)
  • 4.4. Media
    • 4.4.1. Media Market, 2021 - 2033 (USD Million)
  • 4.5. Sera
    • 4.5.1. Sera Market, 2021 - 2033 (USD Million)
  • 4.6. Cell Culture Supplements
    • 4.6.1. Cell Culture Supplements Market, 2021 - 2033 (USD Million)
  • 4.7. Antibodies
    • 4.7.1. Antibodies Market, 2021 - 2033 (USD Million)
  • 4.8. Reagents & Buffers
    • 4.8.1. Reagents & Buffers Market, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. Cell Therapy Raw Materials Market: End Use Movement Analysis
  • 5.2. Biopharmaceutical & Pharmaceutical Companies
    • 5.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2021 - 2033 (USD Million)
  • 5.3. CROs & CMOs
    • 5.3.1. CROs & CMOs Market, 2021 - 2033 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Cell Therapy Raw Materials Market Share By Region, 2025 & 2033
  • 6.2. North America
    • 6.2.1. North America Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Competitive Scenario
      • 6.2.4.3. Regulatory Framework
      • 6.2.4.4. Mexico Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Argentina Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Cell Therapy Raw Materials Market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Position Analysis, 2025
  • 7.4. Company Profiles
    • 7.4.1. Thermo Fisher Scientific Inc.
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Merck KGaA
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Actylis.
      • 7.4.3.1. Overview
      • 7.4.3.2. Product Benchmarking
      • 7.4.3.3. Strategic Initiatives
    • 7.4.4. ACROBiosystems
      • 7.4.4.1. Overview
      • 7.4.4.2. Product Benchmarking
      • 7.4.4.3. Strategic Initiatives
    • 7.4.5. STEMCELL Technologies
      • 7.4.5.1. Overview
      • 7.4.5.2. Product Benchmarking
      • 7.4.5.3. Strategic Initiatives
    • 7.4.6. Grifols, S.A.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Charles River Laboratories
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. RoosterBio, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Product Benchmarking
      • 7.4.8.3. Strategic Initiatives
    • 7.4.9. PromoCell GmbH
      • 7.4.9.1. Overview
      • 7.4.9.2. Product Benchmarking
      • 7.4.9.3. Strategic Initiatives
    • 7.4.10. Danaher
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Sartorius Stedim Biotech
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제